Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes far beyond annotations by detailing data sources (SEC EDGAR/XBRL, FAERS), specific metrics (revenue, net income, cash, long-term debt; FAERS counts, FDA approvals, trials), fiscal-year handling, sorting by primary metric, and return of citation URIs. Annotations only state read-only/idempotent, so this context is highly valuable.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and slightly long, but every sentence adds value—examples, precedence rule, per-type data details, sorting, output, and efficiency rationale. It is well-structured and front-loaded with usage examples, though it could be trimmed without losing critical info.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully covers what data is returned for each entity type, how results are sorted, and that citation URIs are included. It also addresses edge cases like off-calendar fiscal years and quantifies efficiency, making it self-sufficient for an agent.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers both parameters with examples, but the description adds meaning by explaining what each type pulls (company vs drug) and gives concrete value examples. This enriches the schema's bare definitions with real-world usage context.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description explicitly states the tool performs side-by-side comparison of 2–5 companies or drugs in one parallel call, with concrete trigger phrases like 'X vs Y' and 'which is bigger'. It clearly differentiates from sequential single-entity lookups by saying 'ALWAYS PREFER over sequential single-pack lookups when comparing entities'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit when-to-use guidance: use for comparison queries and prefer over sequential lookups. It names the alternative approach (sequential single-pack lookups) but does not mention specific sibling tools like entity_profile, which would make it a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.2/5.0
Disambiguation2/5

Many tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, discover_tools, and suggest_questions all route to the same underlying data catalog. The six polymarket_* tools also blur together (edges, arbitrage, edge_tracker, fill_risk, kalshi_spread), and resolve vs resolve_entity is an outright collision an agent will likely misselect.

Naming Consistency3/5

There is a solid verb_noun core (list_subscriptions, scan_dependency, validate_claim, suggest_questions, compare_entities) but it is mixed with bare nouns (enrichment, homology, interactions, network) and product-prefixed names (pipeworx_feedback, polymarket_edges, ask_pipeworx). No single consistent pattern holds across the set, though the clusters are internally predictable.

Tool Count2/5

At 36 tools this is well above the 25+ threshold for 'too many,' and the sprawl is not justified by a single coherent domain—prediction markets, bioinformatics, brand visibility, npm scanning, and subscription management are jammed together. The count makes the tool surface hard to navigate even with good descriptions.

Completeness4/5

Within each major cluster the lifecycle feels covered: memory (remember/recall/forget), subscriptions (subscribe/unsubscribe/list/recent_alerts), STRING-DB (resolve/homology/interactions/network/enrichment), and Polymarket analysis (scan/edge/arb/fill-risk/track) all form reasonably complete workflows. The main gap is that the server attempts so many domains that none is exhaustively deep, but there are no critical dead ends.